Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling

Acting on the cytokine cascade is key to preventing disease progression and death in hospitalised patients with COVID-19. Among anti-cytokine therapies, interleukin (IL)-6 inhibitors have been the most used and studied since the beginning of the pandemic. Going through previous observational studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Zizzo, Gaetano, Tamburello, Antonio, Castelnovo, Laura, Laria, Antonella, Mumoli, Nicola, Faggioli, Paola Maria, Stefani, Ilario, Mazzone, Antonino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948465/
https://www.ncbi.nlm.nih.gov/pubmed/35340805
http://dx.doi.org/10.3389/fimmu.2022.795315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948465/
https://www.ncbi.nlm.nih.gov/pubmed/35340805
http://dx.doi.org/10.3389/fimmu.2022.795315

Ejemplares similares